Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7842672 Phosphonate inhibitors of HCV

Patent 7842672 was granted and assigned to Gilead Sciences on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kuei-Ying Lin0

Alan X. Huang0

Choung U. Kim0

Constantine G. Boojamra0

David A. Oare0

James M. Chen0

Jason K. Perry0

Lijun Zhang0

...

Date of Patent

November 30, 2010

0

Patent Application Number

118253950

Date Filed

July 6, 2007

0

Patent Citations Received

US Patent 11926645 Compounds and methods for treatment of viral infections

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

0

US Patent 11975016 2′-substituted-N

0

US Patent 11975012 Remdesivir treatment methods

0

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

0

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

0

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

0

...

Patent Primary Examiner

Patrick T. Lewis

0

Patent abstract

A compound of Formula I, Formula II, Formula III, or Formula IV:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7842672 Phosphonate inhibitors of HCV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.